{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:52:28Z","timestamp":1791337948215,"version":"4.3.1"},"reference-count":40,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2010,11,16]],"date-time":"2010-11-16T00:00:00Z","timestamp":1289865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Background\u2002<\/jats:bold>\n                    Congenital adrenal hyperplasia caused by classic 21\u2010hydroxylase deficiency (21OHD) is an autosomal recessive disorder with a high prevalence of asymptomatic heterozygote carriers (HTZ) in the general population, making case detection desirable by routine methodology. HTZ for classic and nonclassic (NC) forms have basal and ACTH\u2010stimulated values of 17\u2010hydroxyprogesterone (17OHP) that fail to discriminate them from the general population. 21\u2010Deoxycortisol (21DF), an 11\u2010hydroxylated derivative of 17OHP, is an alternative approach to identify 21OHD HTZ.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Objective\u2002<\/jats:bold>\n                    To determine the discriminating value of basal and ACTH\u2010stimulated serum levels of 21DF in comparison with 17OHP in a population of HTZ for 21OHD (\n                    <jats:italic>n<\/jats:italic>\n                    \u2003=\u200360), as well as in NC patients (\n                    <jats:italic>n<\/jats:italic>\n                    \u2003=\u200316) and in genotypically normal control subjects (CS,\n                    <jats:italic>n<\/jats:italic>\n                    \u2003=\u200330), using fourth generation tandem mass spectrometry after HPLC separation (LC\u2010MS\/MS).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results\u2002<\/jats:bold>\n                    Basal 21DF levels were not different between HTZ and CS, but stimulated values were increased in the former and virtually nonresponsive in CS. Only 17\u00b77% of the ACTH\u2010stimulated 21DF levels overlapped with CS, when compared to 46\u00b78% for 17OHP. For 100% specificity, the sensitivities achieved for ACTH\u2010stimulated 21DF, 17OHP and the quotient [(21DF\u2003+\u200317OHP)\/F] were 82\u00b73%, 53\u00b72% and 87%, using cut\u2010offs of 40, 300\u2003ng\/dl and 46 (unitless), respectively. Similar to 17OHP, ACTH\u2010stimulated 21DF levels did not overlap between HTZ and NC patients. A positive and highly significant correlation (\n                    <jats:italic>r<\/jats:italic>\n                    \u2003=\u20030\u00b7846;\n                    <jats:italic>P<\/jats:italic>\n                    \u2003&lt;\u20030\u00b7001) was observed between 21DF and 17OHP pairs of values from NC and HTZ.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion\u2002<\/jats:bold>\n                    This study confirms the superiority of ACTH\u2010stimulated 21DF, when compared to 17OHP, both measured by LC\u2010MS\/MS, in identifying carriers for 21OHD. Serum 21DF is a useful tool in genetic counselling to screen carriers among relatives in families with affected subjects, giving support to molecular results.\n                  <\/jats:p>","DOI":"10.1111\/j.1365-2265.2010.03871.x","type":"journal-article","created":{"date-parts":[[2010,9,16]],"date-time":"2010-09-16T02:26:35Z","timestamp":1284603995000},"page":"700-706","source":"Crossref","is-referenced-by-count":37,"title":["Superior discriminating value of ACTH\u2010stimulated serum 21\u2010deoxycortisol in identifying heterozygote carriers for 21\u2010hydroxylase deficiency"],"prefix":"10.1111","volume":"73","author":[{"given":"Fl\u00e1via A.","family":"Costa\u2010Barbosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e2nia F.","family":"Tonetto\u2010Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valdemir M.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odete H.","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Moura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00e2nia A. S. S.","family":"Bachega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 G. H.","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio E.","family":"Kater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,11,16]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.21.3.245"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra021561"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0062"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1645"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmh047"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.78.4.810"},{"key":"e_1_2_7_8_2","first-page":"181","volume-title":"Androgen Excess Disorders in Women","author":"Azziz R.","year":"1997"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19980401)76:4<337::AID-AJMG9>3.0.CO;2-M"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03348240"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-66-4-659"},{"issue":"1","key":"e_1_2_7_12_2","first-page":"41","article-title":"Detection of heterozygotes for 21\u2010hydroxylase deficiency: validation of 21\u2010deoxycortisol after ACTH test by sequencing of the entire CYP21 gene","volume":"64","author":"Tardy V.","year":"2005","journal-title":"Hormone Research"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2008.07.035"},{"key":"e_1_2_7_14_2","first-page":"1","volume-title":"Protocols for determination of limits of detection and limits of quantification; Approved guideline (NCCLS document EP17\u2010A, ISBN 1\u201056238\u2010551\u20108)","author":"Tholen D.W.","year":"2004"},{"key":"e_1_2_7_15_2","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1210\/jcem.87.2.8247","article-title":"Variable ACTH\u2010stimulated 17\u2010hydroxyprogesterone values in 21\u2010hydroxylase deficiency carriers are not correlated to different CYP21 gene mutations","volume":"87","author":"Bachega T.A.","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2001-011939"},{"key":"e_1_2_7_17_2","unstructured":"Mota E.R. Bachega T.A. Nishi M.Y.et\u00a0al.(2008)Comparison between Southern Blot and Multiplex Ligation Probe amplification techniques for detection of large rearrangements involving CYP21 genes in patients with 21\u2010hydroxylase deficiency. Program of the the Annual Meeting of the Endocrine Society San Francisco SF 2008; 500 pp."},{"key":"e_1_2_7_18_2","first-page":"4028","article-title":"Genotyping steroid 21\u2010hydroxylase deficiency: hormonal reference data","volume":"92","author":"New M.I.","year":"1983","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115897"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1890"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2890"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(77)80561-1"},{"key":"e_1_2_7_23_2","first-page":"507","article-title":"Detection of heterozygote carrier for 21\u2010hydroxylase deficiency by plasma 21\u2010deoxycortisol measurements","volume":"116","author":"Gourmelen M.","year":"1987","journal-title":"Acta Endocrinologica"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1177\/000456329403100110"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1214"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(77)80560-X"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(83)90231-5"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-57-5-1061"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)91185-D"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-0760(99)00151-X"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/chromsci\/41.5.251"},{"key":"e_1_2_7_32_2","first-page":"199","article-title":"Diagnosis of adrenal cortical dysfunction by liquid chromatography\u2010tandem mass spectrometry","volume":"31","author":"Kao P.C.","year":"2001","journal-title":"Annals of Clinical and Laboratory Science"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-032235"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.1284"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004390050586"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1582"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(99)00317-9"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2006.02521.x"},{"issue":"5","key":"e_1_2_7_39_2","first-page":"1315","article-title":"The role of heterozygosity for CYP21 in the polycystic ovary syndrome","volume":"13","author":"Witchel S.F.","year":"2000","journal-title":"Journal of Pediatric Endocrinology and Metabolism"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.1.7131"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2000.00995.x"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2010.03871.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.2010.03871.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T16:38:26Z","timestamp":1698770306000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.2010.03871.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,16]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["10.1111\/j.1365-2265.2010.03871.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2010.03871.x","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.7501963.7796067","asserted-by":"object"}]},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,16]]}}}